CytoSorbents Stock Price

0.06 (2.96%)
Upgrade to Real-Time
Regular Market
Volume 99,106
Bid Price 2.07
Ask Price 2.09
News -
Day High 2.18


52 Week Range


Day Low 1.95
Company Name Stock Ticker Symbol Market Type
CytoSorbents Corporation CTSO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 2.96% 2.09 13:39:55
Open Price Low Price High Price Close Price Prev Close
1.95 1.95 2.18 2.03
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,023 99,106 $ 2.05 $ 203,525 - 1.69 - 9.80
Last Trade Time Type Quantity Stock Price Currency
13:38:21 300 $ 2.09 USD


Draw Mode:

CytoSorbents Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 91.08M 43.58M 42.59M $ 40.11M $ -36.72M -0.58 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 64.60k 46.20%

more financials information »

CytoSorbents News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTSO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.002.47721.801.99455,3390.094.5%
1 Month2.292.47721.802.02192,557-0.20-8.73%
3 Months1.922.651.692.10277,8490.178.85%
6 Months3.804.151.692.37239,451-1.71-45.0%
1 Year7.439.801.694.15245,275-5.34-71.87%
3 Years4.8913.891.696.99350,622-2.80-57.26%
5 Years4.7014.951.697.46288,324-2.61-55.53%

CytoSorbents Description

CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries. The company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend and others. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending. Geographically it derives substantial revenue from product sales in Germany.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now